Healthcare -
Drug Manufacturers - General - NASDAQ - US
$ 140.55
-0.481 %
$ 20.5 B
Market Cap
12.72
P/E
BIIB - REVENUE
Revenue BIIB - Biogen Inc.
9.84 B
LAST VALUE
-5.36%
2 YEAR CAGR
-6.07%
5 YEAR CAGR
3.56%
10 YEAR CAGR